

Author: Salvador Javier Gomez-Ambrosi Javier Frühbeck Gema
Publisher: Informa Healthcare
ISSN: 1465-6566
Source: Expert Opinion on Pharmacotherapy, Vol.2, Iss.10, 2001-10, pp. : 1615-1622
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content




The therapeutic potential of leptin
By Proietto Joseph Thorburn Anne W
Expert Opinion on Investigational Drugs, Vol. 12, Iss. 3, 2003-03 ,pp. :




Shp2 as a therapeutic target for leptin resistance and obesity
Expert Opinion on Therapeutic Targets, Vol. 10, Iss. 1, 2006-02 ,pp. :